September 21, 2020 Initiative offers financial support for novel approaches and enabling technologies in crop researchBayer opens application window for Grants4AgRead more
SPECIALIZED PRESS September 17, 2020 ESMO Virtual Congress 2020:New data reinforce strong clinical profile of Vitrakvi™ for patients of all ages with TRK Fusion Cancer including lung and thyroid tumorsRead more
September 15, 2020 Bayer Launches Large-scale Pre-launch Trial of New Tomato Varieties with Resistance to Tomato Brown Rugose Fruit Virus (ToBRFV)Read more
SPECIALIZED PRESS September 15, 2020 Not intended for U.S. and UK MediaBayer and Systems Oncology sign exclusive license agreement on innovative breast cancer treatment approach ERSO™ Read more
September 10, 2020 Bayer: Supervisory Board extends CEO Werner Baumann’s contract until the end of April 2024Read more
SPECIALIZED PRESS September 9, 2020 Not intended for U.S. and UK MediaNew England Journal of Medicine publishes final overall survival data for Nubeqa™ (darolutamide) showing treatment significantly extends life in men with non-metastatic prostate cancerRead more
September 9, 2020 Bayer collaborates with Recursion to strengthen digital drug discovery and advance new therapies for fibrotic diseasesRead more
SPECIALIZED PRESS September 9, 2020 Not intended for U.S. and UK MediaBayer completes acquisition of UK-based biotech company KaNDy Therapeutics Ltd.Read more
SPECIALIZED PRESS September 8, 2020 Not intended for U.S. and UK MediaBayer to showcase new data from evolving Oncology portfolio at ESMO Virtual Congress 2020Read more
SPECIALIZED PRESS August 28, 2020 Not intended for U.S. and UK MediaBayer submits vericiguat for marketing authorization in China for the treatment of chronic heart failureRead more
